A systematic review of the barriers and facilitators impacting patient enrolment in clinical trials for lung cancer

• Published in: European journal of oncology nursing : the official journal of European Oncology Nursing Society Vol. 70; p. 102564
• Main Authors: Lond, Benjamin, Dodd, Christopher, Davey, Zoe, Darlison, Liz, McPhelim, John, Rawlinson, Janette, Williamson, Iain, Merriman, Clair, Waddington, Francesca, Bagnallainslie, Dominic, Rajendran, Balaji, Usman, Jesse, Henshall, Catherine
• Format: Journal Article
• Language: English
• Published: Scotland Elsevier Ltd 01-06-2024
• Subjects: Clinical trials; Lung cancer; Recruitment; Systematic review; Clinical trials; Systematic review; Lung cancer; Recruitment
• ISSN: 1462-3889; 1532-2122; 1532-2122
• DOI: 10.1016/j.ejon.2024.102564

Clinical research trials are needed to enhance the medical care and treatment for lung cancer, which remains the leading cause of cancer-related deaths worldwide. While clinical trials allow for the development of novel therapies to treat cancer, the recruitment of lung cancer patients to trials is low. This review aimed to identify and synthesise the available literature concerning barriers and facilitators affecting lung cancer patients’ decisions to enrol in clinical trials to guide future cancer research efforts.
Four databases were systematically searched: Academic Search Complete, CINHAL, PubMed, and PsycINFO in August 2023. A supplemental grey literature search was also conducted alongside this. Articles were quality appraised using CASP and JMI checklists, and results were narratively synthesised.
Eighteen articles of varied design met the inclusion criteria, and results were mapped onto the Capability, Opportunity, and Motivation Behaviour (COM-B) Model to help structure and conceptualise review findings. Evidence suggests that the decision to enrol in a trial is multifaceted and informed by: when and how study information is presented, travel and trial eligibility, and altruistic hopes and fears.
There is need to address the many different concerns that lung cancer patients have about participating in a clinical trial through the supply of accessible and timely trial information, and via the reduction of travel, expansion of study eligibility criteria, and recognition of a person's altruistic wishes, hopes, fears, and family-oriented concerns. Future research should aim to work alongside lung cancer patients, clinicians, and other stakeholders to increase research accessibility.
•The decision to enrol in a clinical trial for lung cancer is multifaceted.•Study information, travel and trial eligibility, and beliefs impact enrolment.•Researchers should address lung cancer patients' material and psychosocial concerns.